Deferred Income Tax Expense (Benefit) of Fusion Pharmaceuticals Inc. from 31 Dec 2019 to 31 Mar 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Fusion Pharmaceuticals Inc. quarterly and annual Deferred Income Tax Expense (Benefit) in USD history and change rate from 31 Dec 2019 to 31 Mar 2024.
  • Fusion Pharmaceuticals Inc. Deferred Income Tax Expense (Benefit) for the quarter ending 31 Mar 2024 was $405,000, a 18% increase year-over-year.
  • Fusion Pharmaceuticals Inc. annual Deferred Income Tax Expense (Benefit) for 2023 was $845,000.
  • Fusion Pharmaceuticals Inc. annual Deferred Income Tax Expense (Benefit) for 2022 was $3,162,000, a 219% decline from 2021.
  • Fusion Pharmaceuticals Inc. annual Deferred Income Tax Expense (Benefit) for 2021 was $991,000, a 72% decline from 2020.
Source SEC data
View on sec.gov
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Change (%)
Deferred Income Tax Expense (Benefit), Annual (USD)
Deferred Income Tax Expense (Benefit), YoY Annual Change (%)

Fusion Pharmaceuticals Inc. Quarterly Deferred Income Tax Expense (Benefit) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $405,000 +$89,000 +18% 01 Jan 2024 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q1 2023 $494,000 -$154,000 -45% 01 Jan 2023 31 Mar 2023 10-Q 07 May 2024 2024 Q1
Q1 2022 $340,000 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023 2023 Q1

Fusion Pharmaceuticals Inc. Annual Deferred Income Tax Expense (Benefit) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2023 $845,000 +$4,007,000 01 Jan 2023 31 Dec 2023 10-K 20 Mar 2024 2023 FY
2022 $3,162,000 -$2,171,000 -219% 01 Jan 2022 31 Dec 2022 10-K 20 Mar 2024 2023 FY
2021 $991,000 -$415,000 -72% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $576,000 -$517,000 -876% 01 Jan 2020 31 Dec 2020 10-K 17 Mar 2022 2021 FY
2019 $59,000 01 Jan 2019 31 Dec 2019 10-K 25 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.